Upload Image (Max 20MB per Image)
Novartis has announced a label change for Gilenya in the US, to include cardiovascular monitoring, while the EMA has called for similar changes in Europe. The US label changes are the result of discussions with the FDA, following ...
Tags: label change for Gilenya, FDA, Medicinal Products